Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
316,555,475
-
Share change
-
+15,299,857
-
Total reported value
-
$11,315,271,578
-
Put/Call ratio
-
82%
-
Price per share
-
$35.69
-
Number of holders
-
764
-
Value change
-
+$543,119,017
-
Number of buys
-
339
-
Number of sells
-
374
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2021
As of 31 Mar 2021,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
764 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
316,555,475 shares.
The largest 10 holders included
Dodge & Cox, Capital International Investors, FMR LLC, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, ROYAL BANK OF CANADA, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and Black Creek Investment Management Inc..
This page lists
764
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.